EP 1556487 A2 20050727 - TRANSPLANTABLE CELL
Title (en)
TRANSPLANTABLE CELL
Title (de)
TRANSPLANTIERBARE ZELLE
Title (fr)
CELLULE TRANSPLANTABLE
Publication
Application
Priority
- EP 03747785 A 20031013
- CH 0300665 W 20031013
- EP 02022868 A 20021014
Abstract (en)
[origin: WO2004035787A2] The invention relates to a human or animal non-totipotent cell which contains at least one nucleic acid which codes for at least one immune modulator by controlling a gene switch molecule which is adjusted by adding an active substance. The invention also relates to the production and use thereof in transplants in order to inhibit transplant rejection and also for the prophylaxis and/or therapy of diseases resulting from a transplant and/or auto immune diseases.
IPC 1-7
C12N 15/12; C12N 15/62; C12N 15/63; C12N 5/06; C12N 5/08; C12N 5/10; A01K 67/027; A61K 35/34; A61K 35/39; C07K 14/705; C07K 14/54; C07K 16/46; C07K 16/00
IPC 8 full level
A01K 67/027 (2006.01); A61K 35/34 (2006.01); A61K 35/39 (2006.01); C07K 14/54 (2006.01); C07K 14/705 (2006.01); C07K 16/00 (2006.01); C07K 16/46 (2006.01); C12N 5/06 (2006.01); C12N 5/07 (2010.01); C12N 5/071 (2010.01); C12N 5/08 (2006.01); C12N 5/10 (2006.01); C12N 15/12 (2006.01); C12N 15/62 (2006.01); C12N 15/63 (2006.01); C12N 15/85 (2006.01); A61K 35/12 (2006.01); A61K 48/00 (2006.01)
CPC (source: EP KR)
A01K 67/0271 (2013.01 - EP); A01K 67/0275 (2013.01 - EP); A61P 1/04 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 5/16 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 19/08 (2017.12 - EP); A61P 21/00 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 37/06 (2017.12 - EP); C12N 5/0676 (2013.01 - EP); C12N 5/10 (2013.01 - KR); C12N 15/63 (2013.01 - EP KR); C12N 15/8509 (2013.01 - EP); A01K 2207/15 (2013.01 - EP); A01K 2217/00 (2013.01 - EP); A01K 2217/05 (2013.01 - EP); A01K 2227/10 (2013.01 - EP); A01K 2227/105 (2013.01 - EP); A01K 2267/025 (2013.01 - EP); A01K 2267/03 (2013.01 - EP); A61K 48/00 (2013.01 - EP); A61K 2035/122 (2013.01 - EP); C07K 2319/30 (2013.01 - EP); C12N 2510/00 (2013.01 - EP); C12N 2517/02 (2013.01 - EP); C12N 2830/008 (2013.01 - EP); C12N 2830/42 (2013.01 - EP); C12N 2830/85 (2013.01 - EP)
Citation (search report)
See references of WO 2004035787A2
Citation (examination)
STROM T B; FIELD L J; RUEDIGER M: "Allogeneic stem cells, clinical transplantation and the origins of regenerative medicine", CURRENT OPINION IN IMMUNOLOGY, CURRENT BIOLOGY LTD, vol. 14, 1 October 2002 (2002-10-01), England, pages 601 - 605, XP004377413
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004035787 A2 20040429; WO 2004035787 A3 20040826; AU 2003266903 A1 20040504; BR 0315286 A 20050830; CA 2502312 A1 20040429; CN 1705744 A 20051207; EP 1556487 A2 20050727; JP 2006502716 A 20060126; KR 20050071579 A 20050707; MX PA05003912 A 20050930; PL 376397 A1 20051227; RU 2005114511 A 20051120
DOCDB simple family (application)
CH 0300665 W 20031013; AU 2003266903 A 20031013; BR 0315286 A 20031013; CA 2502312 A 20031013; CN 200380101413 A 20031013; EP 03747785 A 20031013; JP 2004543888 A 20031013; KR 20057006477 A 20050414; MX PA05003912 A 20031013; PL 37639703 A 20031013; RU 2005114511 A 20031013